Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

President Urges Breaking Down Drug, Device Distinctions, Regulatory Barriers

This article was originally published in The Pink Sheet Daily

Executive Summary

At White House summit on precision medicine, President Obama emphasized the need to break down outmoded regulations, and suggested barriers between drug and device oversight need to be loosened; FDA and NIH announced a number of new competitions and projects.

You may also be interested in...



US FDA’s Precision Medicine Efforts Turn Towards Adverse Events

Next PrecisionFDA challenge aims to detect ‘adverse event anomalies’ including manufacturer-specific patterns and drug-drug interactions.

Califf On Capitol Hill: Rally Friends, Repair Relationships

The new FDA commissioner cautions rare disease advocates about fighting for ineffective treatments and looks to repair communication problems with Senate.

Califf On Capitol Hill: Rally Friends, Repair Relationships

The new FDA commissioner cautions rare disease advocates about fighting for ineffective treatments and looks to repair communication problems with Senate.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS079149

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel